APYX Apyx Medical Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: APYX

Price (delayed)

$3.04

Market cap

$128.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.2

Enterprise value

$140.07M

?
Relative Growth: Rel. Growth: 66
Relative Strength: Rel. Strength: 22
Relative Valuation: Rel. Valuation: 20
Relative Profitability: Rel. Profitability: 39

: Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products in the cosmetic and surgical markets. Known for its innovative ...

Highlights
The EPS has surged by 56% year-on-year and by 9% since the previous quarter
APYX's net income is up by 50% year-on-year and by 6% since the previous quarter
APYX's equity is up by 47% year-on-year but it is down by 17% since the previous quarter
The quick ratio is up by 15% year-on-year but it has declined by 5% since the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://apyxmedical.com
Peers: OFIX

Key stats

What are the main financial stats of APYX

APYX stock price

How has the Apyx Medical stock price performed over time
Intraday
1.67%
1 week
-26.92%
1 month
-28.64%
1 year
29.36%
YTD
-13.14%
QTD
-32.29%

Financial performance

How have Apyx Medical's revenue and profit performed over time
Revenue
$58.42M
Gross profit
$37.09M
Operating income
-$3.54M
Net income
-$8.63M
Gross margin
63.5%
Net margin
-14.8%
Apyx Medical's operating margin has surged by 77% YoY and by 21% QoQ
APYX's operating income has surged by 71% year-on-year and by 18% since the previous quarter
APYX's net margin has soared by 60% YoY and by 10% QoQ
APYX's net income is up by 50% year-on-year and by 6% since the previous quarter

Price vs fundamentals

How does APYX's price correlate with its fundamentals

Growth

What is Apyx Medical's growth rate over time

Valuation

What is Apyx Medical stock price valuation
P/E
N/A
P/B
11.94
P/S
2.18
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.4
The EPS has surged by 56% year-on-year and by 9% since the previous quarter
The price to book (P/B) is 87% higher than the 5-year quarterly average of 6.4 but 10% lower than the last 4 quarters average of 13.2
APYX's equity is up by 47% year-on-year but it is down by 17% since the previous quarter
The stock's price to sales (P/S) is 27% less than its 5-year quarterly average of 3.0 and 16% less than its last 4 quarters average of 2.6
The revenue is up by 26% year-on-year and by 4.5% since the previous quarter

Efficiency

How efficient is Apyx Medical business performance
The return on sales has surged by 81% year-on-year and by 22% since the previous quarter
The return on invested capital has surged by 78% year-on-year and by 21% since the previous quarter
The company's return on assets has surged by 51% YoY and by 7% QoQ
Apyx Medical's return on equity has surged by 51% YoY and by 13% QoQ

Dividends

What is APYX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for APYX.

Financial health

How did Apyx Medical financials performed over time
The total assets is 22% more than the total liabilities
Apyx Medical's current ratio has increased by 20% YoY but it has decreased by 2.1% from the previous quarter
The quick ratio is up by 15% year-on-year but it has declined by 5% since the previous quarter
APYX's equity is up by 47% year-on-year but it is down by 17% since the previous quarter
The company's debt to equity fell by 31% YoY but it rose by 21% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.